Literature DB >> 10743503

Dual role of tumor necrosis factor alpha in brain injury.

E Shohami1, I Ginis, J M Hallenbeck.   

Abstract

Brain injury (ischemia, trauma) is among the leading cause of mortality and disability in the western world. It induces increased production of tumor necrosis factor (TNF alpha) by brain resident cells. There is conflicting evidence on the role of this response in the injured brain, showing its potential effect in both processes of repair and of damage. This review presents data from clinical and experimental studies on the stimulation of TNF alpha production in brain injury and on the deleterious consequence of this acute response. Its inhibition by pharmacologic agents, neutralizing antibodies or soluble receptors has protective effects. In contrast, there are reports (from in-vitro studies or knock-out mice) on the beneficial effects of TNF alpha. To reconcile these apparently conflicting reports, the exact timing and extent of TNF alpha activation must be taken into account, as well as the presence of other mediators such as reactive oxygen species. It is suggested that the appropriate context of mediators, at any given time after brain injury may well determine whether the effect of TNF alpha is protective or toxic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10743503     DOI: 10.1016/s1359-6101(99)00008-8

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  106 in total

1.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

2.  Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.

Authors:  Le Wu; Sen Miao; Lin-Bing Zou; Ping Wu; Hua Hao; Ke Tang; Pan Zeng; Jing Xiong; Hong-Hua Li; Qiang Wu; Lei Cai; Du-Yun Ye
Journal:  J Mol Neurosci       Date:  2012-06-03       Impact factor: 3.444

Review 3.  Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.

Authors:  Na'ama A Shein; Esther Shohami
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

4.  Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures.

Authors:  Yael Yuhas; Abraham Weizman; Shai Ashkenazi
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 5.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 6.  Microglial activation in stroke: therapeutic targets.

Authors:  Midori A Yenari; Tiina M Kauppinen; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

7.  Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Leora M Fox; Kirsten M Lynch; Brian J Zink; Adam Chodobski
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

8.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

9.  Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury.

Authors:  Lital Magid; Sami Heymann; Merav Elgali; Liat Avram; Yoram Cohen; Sigal Liraz-Zaltsman; Raphael Mechoulam; Esther Shohami
Journal:  J Neurotrauma       Date:  2019-02-07       Impact factor: 5.269

Review 10.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.